Written answers

Wednesday, 18 May 2022

Department of Health

Medicinal Products

Photo of John LahartJohn Lahart (Dublin South West, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

177. To ask the Minister for Health when voretigene neparvovec luxturna will be added to the reimbursement list in line with the Health Act 2013 and the national framework agreed with the pharmaceutical industry under which a company must submit an application to the HSE to have a new medicine approved; and if he will make a statement on the matter. [24969/22]

Photo of Stephen DonnellyStephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.

Comments

No comments

Log in or join to post a public comment.